Close Menu

NEW YORK (GenomeWeb News) – Enzo Biochem's Enzo Clinical Labs division will market Ikonisys' OncoFISH cervical test, under an agreement announced today.

Enzo Clinical Labs will have exclusive marketing rights for the test in New York and New Jersey. It will offer the assay to doctors requesting advanced analysis of specimens from liquid-based Pap tests to assist them in evaluating cytologic reports. Ikonisys will conduct the evaluation of the specimen using its own CellOptics platform on the Ikoniscope Digital Microscopy System for interpreting molecular signals.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Senate has confirmed Stephen Hahn as the next commissioner of the Food and Drug Administration, according to the New York Times.

ScienceInsider reports that rude and unprofessional paper reviewers are common and can have harmful effects.

CNBC reports Apple is partnering with Color Genomics to offer its employees free DNA screening for disease.

In Science this week: researchers use CRISPR tool to find gut microbiome molecules involved in immunity, and more.